PHASE 3 TRIALS OF CORONAVIRUS VACCINE DEVELOPED BY NOVAVAX START IN U.S.

Highlights

• In the U.S. and Mexico, the new trials will be conducted on nearly 30,000 volunteers ageing more than 18

• As per the statement the goal is that minimum of 25 percent of the participants in the U.S. and Mexico trials should be aged 65 and over

• Similar phase 3 trial for the same vaccine is currently under way in the United Kingdom and these trials include around 15,000 volunteers